ResvaLife

Name: ResvaLife
Brand: Privell
Price: 99.0 INR
Availability: InStock

Formulation

Cardiovascular HealthPrivell

Interested in this formulation?

Get an MOQ & pricing proposal within 1 business day.

Serving Size 1 Veg Capsule

Servings Per Container 30

Amount Per Serving

Japanese Knotweed Extract (Polygonum cuspidatum 500 mg —

std. to 50% resveratrol) 250 mg —

- Provides: Resveratrol 15 mg —

Red Grape Extract (≥30% polyphenols

* Percent Daily Values are based on a 2,000 calorie diet.

ResvaLife is a nutraceutical supplement formulated to deliver a concentrated dose of natural trans-resveratrol alongside supportive grape polyphenols.
Provides 250 mg pure trans-resveratrol from Japanese Knotweed (Polygonum cuspidatum).
Includes red grape extract (15 mg; ≥30% polyphenols) for synergistic antioxidant activity.
Designed in vegetarian capsules, once-daily dose.
Supports vascular health, endothelial function, and healthy aging.

🌿 Formula Breakdown

What's Inside, By Share

Active Complex

Resveratrol (polyphenolic stilbene) activates SIRT1 and AMPK signaling, enhancing mitochondrial biogenesis and endothelial nitric...

Acts as a potent antioxidant, scavenging ROS and up-regulating endogenous antioxidant enzymes (SOD, catalase).

Pre-clinical evidence

Inhibits platelet aggregation, modulates inflammatory cytokines. (Flagged: pre-clinical)

Adults seeking cardiovascular support.
Individuals with oxidative stress concerns (e.g., aging, environmental stressors).
Suitable for vegetarians and those seeking plant-derived antioxidants.

Generally well-tolerated up to 1 g/day in clinical studies.
Not recommended for:
Individuals on anticoagulant/antiplatelet therapy (warfarin, clopidogrel) without physician oversight.
Pregnant or lactating women (insufficient safety data).
Mild GI upset possible at higher doses.

Wong RHX et al. High dose resveratrol improves flow-mediated dilatation in overweight/obese individuals. J Hypertens. 2011;29(12):2592-2602.
Magyar K et al. Cardiovascular effects of resveratrol in humans: a double-blind, placebo-controlled clinical trial. Clin Hemorheol Microcirc. 2012;50(3):179-187.
Poulsen MM et al. Resveratrol reduces oxidative stress markers in humans: systematic review and meta-analysis. Nutrients. 2015;7(6):4551-4571.
Tomé-Carneiro J et al. Resveratrol supplementation in patients with metabolic syndrome: randomized trial. Nutrients. 2013;5(7):2831-2847.
Olas B et al. Resveratrol inhibits platelet activation: in vitro and animal studies. Thromb Res. 2002;106(2):143-148.